REPLY: High Risk of Gastrointestinal Bleeding on Dual Antiplatelet Treatment

被引：0

作者：

Vaduganathan, Muthiah ^{[1
]}

Bhatt, Deepak L. ^{[1
]}

Cryer, Byron L. ^{[1
]}

Liu, Yuyin ^{[1
]}

Hsieh, Wen-Hua ^{[1
]}

Doros, Gheorghe ^{[1
]}

Cohen, Marc ^{[1
]}

Lanas, Angel ^{[1
]}

Schnitzer, Thomas J. ^{[1
]}

Shook, Thomas L. ^{[1
]}

Lapuerta, Pablo ^{[1
]}

Goldsmith, Mark A. ^{[1
]}

Laine, Loren ^{[1
]}

Cannon, Christopher P. ^{[1
]}

机构：

[1] Brigham & Womens Hosp, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2016年 / 68卷 / 09期

关键词：

EXPERT CONSENSUS DOCUMENTS; PROTON-PUMP INHIBITORS; FOUNDATION TASK-FORCE; NSAID USE; THERAPY;

D O I：

10.1016/j.jacc.2016.06.008

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：981 / 982

页数：3

共 50 条

[31] Safety of Dual Antiplatelet Therapy in Hospitalized Patients With Upper Gastrointestinal Bleeding Undergoing Endoscopy
Saha, Sneha
Lam, Robert
Zheng, Neil
Shung, Dennis
Li, Darrick
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S686 - S687
[32] Incidence, Predictors, and Outcomes of Gastrointestinal Bleeding in Patients on Dual Antiplatelet Therapy With Aspirin and Clopidogrel
Alli, Oluseun
Smith, Colin
Hoffman, Micah
Amanullah, Steven
Katz, Philip
Amanullah, Aman M.
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2011, 45 (05) : 410 - 414
[33] Duration more than type of dual antiplatelet therapy matters in ACS patients with high bleeding risk
Landi, Antonio
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 378 : 10 - 10
[34] Management of Patients with High Gastrointestinal Risk on Antiplatelet Therapy
Cryer, Byron
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2009, 38 (02) : 289 - +
[35] Comparison of Dual Antiplatelet Therapy with Clopidogrel and Ticagrelor in Patients with Acute Coronary Syndrome at High Risk of Bleeding
Zhou, Yafeng
Guo, Ning
Liu, Wei
Paek, Dara
Sayre, Toby
Girotra, Shalini
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (16) : C110 - C111
[36] Dabigatran added to dual antiplatelet therapy to treat a left ventricular thrombus in a patient with high bleeding risk
Noflatscher, M.
Moes, N.
Gassner, E. -M.
Marschang, P.
WIENER KLINISCHE WOCHENSCHRIFT, 2017, 129 : S49 - S49
[37] TRENDS IN DISCHARGE AND OUTCOME OF DUAL ANTIPLATELET THERAPY POST PERCUTANEOUS INTERVENTION IN HIGH BLEEDING RISK POPULATION
Waksman, Ron
Alraies, M. Chadi
Buchanan, Kyle
Koifman, Edward
Steinvil, Arie
Rogers, Toby
Gai, Jiaxiang
Torguson, Rebecca
Ben-Dor, Itsik
Pichard, Augusto
Satler, Lowell
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 1018 - 1018
[38] Thrombin Generation as a Method to Identify the Risk of Bleeding in High Clinical-Risk Patients Using Dual Antiplatelet Therapy
de Breet, C. P. D. M.
Zwaveling, S.
Vries, M. J. A.
van Oerle, R. G.
Henskens, Y. M. C.
Van't Hof, A. W. J.
van der Meijden, P. E. J.
Veenstra, L.
ten Cate, H.
Olie, R. H.
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
[39] Single Antiplatelet Therapy With Prasugrel vs. Dual Antiplatelet Therapy in Japanese Percutaneous Coronary Intervention Patients With High Bleeding Risk
Nakamura, Masato
Kadota, Kazushige
Nakao, Koichi
Nakagawa, Yoshihisa
Shite, Junya
Yokoi, Hiroyoshi
Kozuma, Ken
Tanabe, Kengo
Akasaka, Takashi
Shinke, Toshiro
Ueno, Takafumi
Hirayama, Atsushi
Uemura, Shiro
Harada, Atsushi
Kuroda, Takeshi
Takita, Atsushi
Iijima, Raisuke
Murakami, Yoshitaka
Saito, Shigeru
CIRCULATION JOURNAL, 2021, 85 (06) : 785 - +
[40] INDIVIDUALIZING DURATION OF DUAL ANTIPLATELET THERAPY BASED ON BLEEDING RISK, ISCHEMIC RISK, OR BOTH: AN ANALYSIS FROM THE DUAL ANTIPLATELET THERAPY (DAPT) STUDY
Mihatov, Nino
Secemsky, Eric
Kereiakes, Dean
Steg, Philippe Gabriel
Cutlip, Donald
Kirtane, Ajay
Mehran, Roxana
Zhao, Bokai
Song, Yang
Gibson, C. Michael
Yeh, Robert
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 952 - 952

← 1 2 3 4 5 →